May 4, 2018: Cannavolve signs agreement to manage sales for Vancouver based cannabis firm, Tabu Equity Investments Inc.

May 04, 2018

May 4th, 2018 – Vancouver, British Columbia – Tabu Equity Investments Inc. (the “Company”)  announces that it has signed an LOI with sales agency Cannavolve Inc. Cannavolve Inc. represents companies to out of province cannabis distribution boards. The team will regularly call on retail stores maximizing market share through staff education, distribution compliance, and point-of-sale marketing. Cannavolve Inc. is a dynamic team of executive level professionals from the Canadian beverage alcohol industry with a combined 40+ years experience successfully navigating government networks and regulatory compliance in controlled substances. With their expertise in retail execution, brand building and sales / marketing strategies, they will assist Tabu with sales and marketing across Canada.

Tabu Equity Investments Inc. invests in Canadian ACMPR applicants and licensed United States cannabis technology companies, as well as Canadian based support technologies for the cannabis industry. The company website can be found at:

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Tabu’s periodic filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should, aware” and similar expressions, are forward-looking statements. Forward-looking statements may include, without limitation, statements including statements related to Tabu’s transactions and business related to cannabis and future news releases. Although Tabu has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.


To read full release:

Want to get in touch?